A role for melatonin in humans is becoming evident in an increasing nu
mber of clinical situations. Marked variations in the magnitude of the
nocturnal melatonin peak are observed throughout the human lifespan.
The highest levels occur in children and then fall during puberty and
further during adulthood. A negative correlation between circulating m
elatonin and sex steroids has been observed in a number of instances,
and appears to be independent of concomitant gonadotrophins. No clear
melatonin pattern has been observed in pituitary tumors, but in large
lesions that involve the hypothalamus, a reduced nocturnal rise has be
en reported. Reported effects of exogenously administered melatonin ar
e variable, probably reflecting differences in dose and timing; a slig
ht stimulation of prolactin, as well as a partial inhibition of gonado
trophins, has been reported, which explains its utility as an oral con
traceptive, associated with a progestogen. A potential clinical use of
melatonin as an oncostatic drug still awaits confirmation, although e
xperimental data firmly support this possibility. The indole has also
been used to hasten entrainment of subjects travelling across various
time zones, and has been found to be specially useful in eastward trav
el. Finally, changes in the normal melatonin circadian pattern have be
en reported in psychiatric diseases and in sudden infant death syndrom
e.